Aeglea Biotherapeutics UK Limited
Company profile
DissolvedUnited Kingdom
Ownership evidence
Reported ownership and control rights in this business, with source dates.
Reported ownership & control
1 without an end date · 0 ceasedSpyre Therapeutics, Inc.Corporate
Shares: over 75%, up to 100%Voting rights: over 75%, up to 100%Right to appoint or remove directors
Notified 2019-11-14 · No cessation recorded
Source record 221325881People behind the business
Current appointments and the wider business interests of each person.
Appointments
2 current · 5 historicalHK
Heidy King JonesCurrent director
Appointed 2023-09-01 · 3 yrs · Attorney
SB
Scott BurrowsCurrent director
Appointed 2023-09-01 · 3 yrs · Chief Financial Officer
Show 5 historical appointments
JG
Jeffrey GoldbergResigned director
Resigned 2023-01-25 · Ceo
JK
James KastenmayerResigned director
Resigned 2022-10-21 · General Counsel
JA
Jonathan AlspaughResigned director
Resigned 2022-10-19 · Chief Financial Officer
CY
Charles YorkResigned director
Resigned 2019-11-14 · 1 yr · Vice President And Cfo
AQ
Anthony QuinnResigned director
Resigned 2019-11-14 · 2 yrs · President And Ceo
Board profile
- People with appointments
- 2
- Directors assessed
- —
- Median age
- —
- Under 35
- —
- 65 and over
- —
- Disqualified match
- None active